Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin for Invasive Aspergillosis in China
NCT02646774Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Mar 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of micafungin in invasive aspergillosis (IA), sponsored by Astellas Pharma. Started Mar 2014; status: terminated.
02
Drugs
micafungin
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT02646774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646774.